177 related articles for article (PubMed ID: 6685494)
1. Denzimol, a new anticonvulsant drug. II. General pharmacological activities.
Graziani G; Cazzulani P; Luca C; Nava G; Testa R
Arzneimittelforschung; 1983; 33(8):1161-8. PubMed ID: 6685494
[TBL] [Abstract][Full Text] [Related]
2. Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile.
Graziani G; Tirone F; Barbadoro E; Testa R
Arzneimittelforschung; 1983; 33(8):1155-60. PubMed ID: 6685493
[TBL] [Abstract][Full Text] [Related]
3. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
4. Denzimol, a new anticonvulsant drug. III. Toxicological evaluation.
Graziani G; Barbadoro E; Testa R
Arzneimittelforschung; 1983; 33(8):1168-73. PubMed ID: 6685495
[TBL] [Abstract][Full Text] [Related]
5. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
6. General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
Lee EB; Cho SI; Cheon SA; Chang MS; Kim KB; Sohn SK; Chung YK
Arzneimittelforschung; 1999 Dec; 49(12):1018-24. PubMed ID: 10635448
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
8. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology of the new quinolone antibacterial agent levofloxacin.
Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
[TBL] [Abstract][Full Text] [Related]
10. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activities and side effects of plafibride.
Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
[TBL] [Abstract][Full Text] [Related]
12. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
13. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
15. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity studies on denzimol, a new anticonvulsant drug.
Veronese M; Barzaghi D; Bertoncini A; Zadro M
Arzneimittelforschung; 1985; 35(5):793-6. PubMed ID: 3896246
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
[No Abstract] [Full Text] [Related]
18. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of nizatidine in animals.
Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
[TBL] [Abstract][Full Text] [Related]
20. General pharmacology of IY-81149, a new proton pump inhibitor.
Kim EJ; Lee RK; Lee SM; Kim DY
Arzneimittelforschung; 2001 Jan; 51(1):51-9. PubMed ID: 11215326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
